Otc - Active Ingredient
Active Ingredients (in each 5 mL tsp.)
Dexbrompheniramine Maleate, USP .......... 1 mg .................... Antihistamine
Pseudoephedrine HCL, USP ............ 30 mg ...................... Nasal Decongestant
The following Structured Product Label (SPL) was submitted to the FDA by Llorens Pharmaceutical International Division for the product Conex (NDC 54859-802). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, warnings, otc - do not use, otc - keep out of reach of children, otc - pregnancy or breast feeding, dosage & administration, indications & usage, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Active Ingredients (in each 5 mL tsp.)
Dexbrompheniramine Maleate, USP .......... 1 mg .................... Antihistamine
Pseudoephedrine HCL, USP ............ 30 mg ...................... Nasal Decongestant
Uses:
Warnings:
Ask a doctor before use if you are taking sedatives or tranquilizers.
Ask a doctor before use if you have
Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
If pregnant or breast-feeding, ask a Health Professional before use.
Directions: Do not exceed more than 4 doses in any 24-hour period or as directed by a doctor.
| Age | Dose |
| Adults and children 12 years of age and over | take two teaspoonfuls (10 mL) every 4 to 6 hours |
| Children 6 to under 12 years of age | take one teaspoonful (5 mL) every 4 to 6 hours |
| Children under 6 years of age | ask a doctor |
Other Information:
Inactive Ingredients: aspartame, cherry flavor, citric acid, glycerine, menthol, methylparaben, potassium citrate, potassium sorbate, propylene glycol, propylparaben and purified water.
Questions or Comments? 1-866-595-5598
* Please review the disclaimer below.